posted on 2018-09-11, 00:00authored byStephen Moston
In the 1970s and 1980s the use of performance enhancing drugs
was increasingly being linked to the deaths of elite athletes, mainly
cyclists (Verroken, 2000). As a direct response to these problems,
and to assist in the international standardisation of anti-doping
efforts, in 1999 the World Anti-Doping Agency (WADA) was created.
WADA then developed the first World Anti-Doping Code
(WADA, 2003), which periodically undergoes revisions. The current
edition (WADA, 2009) will be superseded by the third edition,
scheduled for release in 2015. The two papers in this issue (Henne,
Koh, & McDermott, 2013; Waddington, Christiansen, Gleaves,
Hoberman, & Møller, 2013) address an apparent inconsistency
in the Code concerning the inclusion of illicit, non-performance
enhancing drugs (NPEDS).